BofA lowered the firm’s price target on CME Group (CME) to $204 from $212 and keeps an Underperform rating on the shares. Volatility receded significantly in Q3, which dampened exchange volumes across most asset classes, says the analyst, who is cutting near-term EPS estimates for most of the firm’s exchange coverage.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group reports September ADV of 26.1M contracts
- Crypto Currents: Bitcoin surges as cryptocurrency market cap tops $4T
- CME Group price target raised to $312 from $303 at Morgan Stanley
- Freeport-McMoRan, Biogen, Intel, Uranium Energy, CME Trending by Analysts
- Early notable gainers among liquid option names on September 25th